351 related articles for article (PubMed ID: 18782861)
1. All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells.
Tao RH; Maruyama IN
J Cell Sci; 2008 Oct; 121(Pt 19):3207-17. PubMed ID: 18782861
[TBL] [Abstract][Full Text] [Related]
2. The ErbB/HER receptor protein-tyrosine kinases and cancer.
Roskoski R
Biochem Biophys Res Commun; 2004 Jun; 319(1):1-11. PubMed ID: 15158434
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor (EGFR) signaling in cancer.
Normanno N; De Luca A; Bianco C; Strizzi L; Mancino M; Maiello MR; Carotenuto A; De Feo G; Caponigro F; Salomon DS
Gene; 2006 Jan; 366(1):2-16. PubMed ID: 16377102
[TBL] [Abstract][Full Text] [Related]
4. Bivalence of EGF-like ligands drives the ErbB signaling network.
Tzahar E; Pinkas-Kramarski R; Moyer JD; Klapper LN; Alroy I; Levkowitz G; Shelly M; Henis S; Eisenstein M; Ratzkin BJ; Sela M; Andrews GC; Yarden Y
EMBO J; 1997 Aug; 16(16):4938-50. PubMed ID: 9305636
[TBL] [Abstract][Full Text] [Related]
5. Internalization and intracellular sorting of the EGF receptor: a model for understanding the mechanisms of receptor trafficking.
Madshus IH; Stang E
J Cell Sci; 2009 Oct; 122(Pt 19):3433-9. PubMed ID: 19759283
[TBL] [Abstract][Full Text] [Related]
6. Differential and synergistic effects of epidermal growth factor receptor antibodies on unliganded ErbB dimers and oligomers.
Kozer N; Kelly MP; Orchard S; Burgess AW; Scott AM; Clayton AH
Biochemistry; 2011 May; 50(18):3581-90. PubMed ID: 21495621
[TBL] [Abstract][Full Text] [Related]
7. Active and inactive conformations of the epidermal growth factor receptor.
Ferguson KM
Biochem Soc Trans; 2004 Nov; 32(Pt 5):742-5. PubMed ID: 15494003
[TBL] [Abstract][Full Text] [Related]
8. Nerve growth factor receptor TrkA exists as a preformed, yet inactive, dimer in living cells.
Shen J; Maruyama IN
FEBS Lett; 2011 Jan; 585(2):295-9. PubMed ID: 21187090
[TBL] [Abstract][Full Text] [Related]
9. Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction.
Lidke DS; Nagy P; Heintzmann R; Arndt-Jovin DJ; Post JN; Grecco HE; Jares-Erijman EA; Jovin TM
Nat Biotechnol; 2004 Feb; 22(2):198-203. PubMed ID: 14704683
[TBL] [Abstract][Full Text] [Related]
10. Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors.
Sanderson MP; Dempsey PJ; Dunbar AJ
Growth Factors; 2006 Jun; 24(2):121-36. PubMed ID: 16801132
[TBL] [Abstract][Full Text] [Related]
11. Evidence for extended YFP-EGFR dimers in the absence of ligand on the surface of living cells.
Kozer N; Henderson C; Jackson JT; Nice EC; Burgess AW; Clayton AH
Phys Biol; 2011 Dec; 8(6):066002. PubMed ID: 21946082
[TBL] [Abstract][Full Text] [Related]
12. Two GxxxG-like motifs facilitate promiscuous interactions of the human ErbB transmembrane domains.
Escher C; Cymer F; Schneider D
J Mol Biol; 2009 May; 389(1):10-6. PubMed ID: 19361517
[TBL] [Abstract][Full Text] [Related]
13. Role of HER receptors family in development and differentiation.
Casalini P; Iorio MV; Galmozzi E; Ménard S
J Cell Physiol; 2004 Sep; 200(3):343-50. PubMed ID: 15254961
[TBL] [Abstract][Full Text] [Related]
14. EGFR family: structure physiology signalling and therapeutic targets.
Burgess AW
Growth Factors; 2008 Oct; 26(5):263-74. PubMed ID: 18800267
[TBL] [Abstract][Full Text] [Related]
15. Are HER1/EGFR interactions with ligand free HER2 related to the effects of HER1-targeted drugs?
Kurbel S
Med Hypotheses; 2006; 67(6):1355-7. PubMed ID: 16890381
[TBL] [Abstract][Full Text] [Related]
16. ErbB receptors, their ligands, and the consequences of their activation and inhibition in the myocardium.
Fuller SJ; Sivarajah K; Sugden PH
J Mol Cell Cardiol; 2008 May; 44(5):831-54. PubMed ID: 18430438
[TBL] [Abstract][Full Text] [Related]
17. Structure of the extracellular region of HER3 reveals an interdomain tether.
Cho HS; Leahy DJ
Science; 2002 Aug; 297(5585):1330-3. PubMed ID: 12154198
[TBL] [Abstract][Full Text] [Related]
18. Type I growth factor receptors: current status and future work.
Gullick WJ
Biochem Soc Symp; 1998; 63():193-8. PubMed ID: 9513723
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor mutant with wild-type affinity for both ErbB1 and ErbB3.
Wingens M; Jacobs-Oomen S; van der Woning SP; Stortelers C; van Zoelen EJ
Biochemistry; 2006 Apr; 45(14):4703-10. PubMed ID: 16584205
[TBL] [Abstract][Full Text] [Related]
20. The transmembrane domains of ErbB receptors do not dimerize strongly in micelles.
Stanley AM; Fleming KG
J Mol Biol; 2005 Apr; 347(4):759-72. PubMed ID: 15769468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
